Our observations suggest that rejuvenating IKKε signaling via targeting of IKBKE eRNA in combination with radiation could be an effective means to trigger anticancer immunity in immunologically “cold” cancers such as prostate cancer. The gene discussed is IKBKE; the disease is Familial prostate cancer.